Duodenopancreatic endocrine tumors are the most frequently lethal part of MEN-1. The management of these patients is complicated by the variable hormonal function of the tumors, and the often indolent but occasionally lethal nature of the tumors. This article reviews our current approach to the diagnosis, surveillance and management of these patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-7404(03)00038-0 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!